ISTARI ONCOLOGY, INC.

Profile

Company Names

ISTARI ONCOLOGY, INC.

Addresses

430 DAVIS DRIVE, SUITE 560, MORRISVILLE, NC 27560

6 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC 27709

Phone Numbers

919-245-7662
919-226-3082

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2014

State Incorporated:

NORTH CAROLINA

Total Amount Raised:

$48,594,777.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-03-08 
$43,481,976.00 
$70,000,000.00 
$26,518,024.00 
Equity 
2
2017-05-20 
$1,112,828.00 
$4,000,000.00 
$2,887,172.00 
Equity 
1
2017-01-27 
$3,999,973.00 
$3,999,973.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARC 
 
BANJAK 
EXECUTIVE OFFICER
ISTARI ONCOLOGY, INC.   |  IBIO, INC.
DARELL 
D. 
BIGNER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ISTARI ONCOLOGY, INC.
DANI 
P. 
BOLOGNESI 
EXECUTIVE OFFICER, DIRECTOR
ISTARI ONCOLOGY, INC.
ROBERT 
 
BONCZEK 
EXECUTIVE OFFICER, DIRECTOR
NEUROP, INC.   |  CELLECTIVE BIOTHERAPY, INC.   |  ISTARI ONCOLOGY, INC.   |  TRACKX TECHNOLOGY, LLC   |  DEEP BLUE MEDICAL ADVANCES, INC.   |  TRACKX TECHNOLOGY, INC.
RAYMOND 
 
CHEONG 
DIRECTOR
ISTARI ONCOLOGY, INC.   |  VTV THERAPEUTICS INC.
TIMOTHY 
J. 
CREECH 
EXECUTIVE OFFICER
ISTARI ONCOLOGY, INC.
MATTHEW 
W. 
FARBER 
EXECUTIVE OFFICER
ISTARI ONCOLOGY, INC.
HENRY 
 
FRIEDMAN 
EXECUTIVE OFFICER
ISTARI ONCOLOGY, INC.
WILLIAM 
G. 
NICHOLS 
EXECUTIVE OFFICER
ISTARI ONCOLOGY, INC.
SEAN 
P. 
NOLAN 
DIRECTOR
ISTARI ONCOLOGY, INC.   |  TAYSHA GENE THERAPIES, INC.
VICTOR 
 
SANDOR 
DIRECTOR
MAGMA TRADING USA, LLC   |  PRELUDE THERAPEUTICS INC   |  ISTARI ONCOLOGY, INC.
MATTHEW 
R. 
STOBER 
EXECUTIVE OFFICER, DIRECTOR
X-VAX TECHNOLOGY, INC.   |  ISTARI ONCOLOGY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-08 
2017-05-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-20 
2017-02-15
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#